The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Changed Microbiome After Caesarean Birth Impacts Baby’s Immune System, Research by LCSB Finds
Pharma & Human Health

Changed Microbiome After Caesarean Birth Impacts Baby’s Immune System, Research by LCSB Finds

DEC 1, 2018
Vedanta Biosciences Announces Initiation of Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for IBD
Clinical & Manufacturing

Vedanta Biosciences Announces Initiation of Phase 1 Clinical Study with Janssen of Microbiome-Derived Product Candidate for IBD

NOV 27, 2018
New finding adds proof microbes are at Alzheimer’s “crime scene”, says Dr. Leslie Norins, CEO of Alzheimer’s Germ Quest, Inc.
Gut-Brain Axis

New finding adds proof microbes are at Alzheimer’s “crime scene”, says Dr. Leslie Norins, CEO of Alzheimer’s Germ Quest, Inc.

NOV 23, 2018
Pharmabiotics Young Investigator Awards: Supporting Tomorrow’s Microbiome Opinion Leaders
Editor's Choice

Pharmabiotics Young Investigator Awards: Supporting Tomorrow’s Microbiome Opinion Leaders

NOV 22, 2018
Synthetic Biologics Announces Positive Outcome of End-of-Phase 2 Meeting with FDA on SYN-004 (ribaxamase) Development
Clinical & Manufacturing

Synthetic Biologics Announces Positive Outcome of End-of-Phase 2 Meeting with FDA on SYN-004 (ribaxamase) Development

NOV 22, 2018
Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing
Pharma & Human Health

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

NOV 21, 2018
6th Microbiome R&D and Business Collaboration Forum USA Summary
Editor's Choice

6th Microbiome R&D and Business Collaboration Forum USA Summary

NOV 20, 2018
Trace Genomics Raises $13m Series A Round to Unlock the Power of the Soil for Farmers
Finance

Trace Genomics Raises $13m Series A Round to Unlock the Power of the Soil for Farmers

NOV 14, 2018
Saliva-Based RNA Panel Accurately Distinguishes Children with Autism Spectrum Disorder from Non-Autistic Peers
Gut-Brain Axis

Saliva-Based RNA Panel Accurately Distinguishes Children with Autism Spectrum Disorder from Non-Autistic Peers

NOV 13, 2018
4D Pharma plc Announces First Patient Enrolment in Blautix IBS Phase II study
Clinical & Manufacturing

4D Pharma plc Announces First Patient Enrolment in Blautix IBS Phase II study

NOV 9, 2018
Pivot Bio, Bayer Announce Research Collaboration To Enhance Soybean Inoculant
Phytobiome & Environment

Pivot Bio, Bayer Announce Research Collaboration To Enhance Soybean Inoculant

NOV 8, 2018